ASX:NEU
ASX:NEUPharmaceuticals

Why Neuren Pharmaceuticals (ASX:NEU) Is Down 14.6% After Revised DAYBUE Sales and Royalty Outlook

Earlier this week, Neuren Pharmaceuticals announced record Q3 2025 DAYBUE™ sales of US$101.1 million and provided an updated royalty outlook as Acadia Pharmaceuticals narrowed its full-year U.S. net sales forecast for the Rett syndrome drug. This development highlights both strong demand for DAYBUE and the sensitivity of Neuren's earnings to royalty projections and its partnership with Acadia. We'll now examine how strong DAYBUE sales growth and the revised royalty outlook influence Neuren's...
ASX:IPH
ASX:IPHProfessional Services

Did CEO Succession Plans Just Shift IPH's (ASX:IPH) Investment Narrative?

IPH Limited recently announced that CEO Dr. Andrew Blattman will retire in the second half of 2026, prompting the company to begin a formal search for a new leader from both internal and external candidates. Dr. Blattman’s lengthy tenure saw IPH expand its footprint in Asia and enter the Canadian market, which has helped shape the group’s international presence and long-term direction. We'll examine how the planned CEO transition and leadership search may impact IPH's investment outlook and...
ASX:AYA
ASX:AYAHealthcare Services

Can Anticipation Around Artrya (ASX:AYA)'s Earnings Call Reveal Shifts in Investor Confidence?

Artrya Limited has announced its upcoming Q1 2026 earnings call, scheduled for October 29, 2025, signaling a key moment for stakeholders awaiting developments from the company. This earnings call has captured increased user attention, reflecting heightened anticipation in the absence of other major company announcements in recent weeks. We'll explore how anticipation around Artrya's upcoming earnings call shapes the company's investment narrative and investor expectations. Explore 27 top...
ASX:WTC
ASX:WTCSoftware

WiseTech Global (ASX:WTC): Evaluating Valuation as CargoWise Growth Outpaces Share Price Recovery

The latest uptick in attention toward WiseTech Global (ASX:WTC) stems from its ongoing growth in revenue and profits, as well as increased use of its CargoWise logistics platform by leading industry players. See our latest analysis for WiseTech Global. Despite the encouraging momentum in its logistics business, WiseTech Global’s share price return has tumbled in 2024, most recently closing at A$66.17 and down more than 46% year-to-date. Still, with a five-year total shareholder return of over...
ASX:SMI
ASX:SMIMetals and Mining

Santana Minerals (ASX:SMI): Assessing Valuation Following Key Mining Permit for Rise & Shine Gold Project

Santana Minerals (ASX:SMI) has secured a key mining permit for its Bendigo-Ophir Gold Project in Central Otago, New Zealand. This 25-year approval allows the company to fully extract and process gold from the Rise & Shine deposit and neighboring areas. This marks a significant milestone as the project moves closer to construction and eventual production. See our latest analysis for Santana Minerals. After a year marked by steady progress, Santana Minerals’ share price has climbed 79%...
ASX:ALX
ASX:ALXInfrastructure

How Atlas Arteria’s Executive Streamlining Could Reshape Cost Efficiency and Accountability (ASX:ALX)

Atlas Arteria has announced a significant restructuring of its executive team, reducing its size to four members and broadening the responsibilities of key leaders, with Vincent Portal-Barrault set to become CFO and Amanda Baxter appointed Chief Commercial Officer, both effective November 10, 2025. This overhaul is designed to streamline leadership, cut corporate costs, and strengthen accountability across the company’s four value-creation pillars as part of its strategy to deliver premium...
ASX:CQR
ASX:CQRRetail REITs

Charter Hall Retail REIT (ASX:CQR): Examining Valuation After Upgraded FY2026 Earnings and Dividend Guidance

Charter Hall Retail REIT (ASX:CQR) has delivered an update that is catching investor attention, with lifted earnings guidance for FY2026 and increased dividend expectations. These changes signal improved returns for shareholders and a positive outlook heading into the new year. See our latest analysis for Charter Hall Retail REIT. Momentum is clearly building for Charter Hall Retail REIT, with the share price up almost 30% year to date as upbeat FY2026 guidance and recent leadership additions...
ASX:AGL
ASX:AGLIntegrated Utilities

Battery Investment and Mandatory Free Solar Might Change The Case For Investing In AGL Energy (ASX:AGL)

In recent days, AGL Energy submitted its 500MW/2,000MWh Tuckeroo Battery project in Queensland for federal environmental approval and is preparing for new regulatory requirements starting in 2026, including the government-mandated provision of three hours of free daily solar electricity to customers. This simultaneous push for major grid-scale battery investment and regulatory-driven changes highlights rising pressure on AGL’s future profit margins, dividends, and long-term investment...